Stevia Corp. (STEV) 0.1920 $STEV
TRAUB Completes Strategic Partnership between "In the Soup" and Stevia Corp.
Business Wire - Wed Apr 09, 8:02AM CDT
TRAUB's Consumer Food and Beverage division has arranged for a strategic partnership between "In The Soup," a Colorado based company with a line of Natural and Organic Premium Soups, with Stevia Corp, the international farm management company focused on the development of products that support a healthy lifestyle.
Stevia Corp. Enters Strategic Partnership With 'In The Soup' and TRAUB's Consumer Food and Beverage Group
Marketwire - Tue Apr 08, 7:41AM CDT
Stevia Corp. (OTCQB: STEV) ("Stevia Corp" or the "Company"
, an international farm management company focused on the economic development of products that support a healthy lifestyle, including stevia and hemp, is pleased to announce the Company has entered into a convertible note financing agreement with YOPCP, LLC, a Colorado based manufacturer of 'In The Soup,' a line of Natural and Organic Premium Soups sold in classic glass jars.
G. Willi-Food Announces its Entrance into the Soft Drinks Market as it Becomes the First Israeli Distributor of Stevia Sweetened Cola
PR Newswire - Wed Apr 02, 12:10PM CDT
ï"
Sugar Substitute Market by Types (HFS, HIS & LIS) Worth $13.7 Billion by 2018 - New Report by MarketsandMarkets
PRWeb - Tue Mar 18, 8:47AM CDT
The report "Sugar Substitute Market - By Types (HFS, HIS & LIS), Subtypes (Stevia, Sorbitol, Tagatose, Aspartame, Saccharine, Sucralose, Xylitol & Others) & Applications (Healthcare & Personal Care, Beverage & Food) - Global Trends, Forecasts to 2018" defines and segments the global sugar substitute market with analysis of current demand and forecasted consumption in terms of volume and revenue.
Diabetes: Herbal Bioactive Molecules Vs. Pharmaceutical Drugs - Volume 1: Cinnamon Global Markets, Competitors And Opportunities - 2014-2019 Analysis And Forecasts
M2 - Fri Mar 14, 10:38AM CDT
Research and Markets (http://www.researchandmarkets.com/research/b4bhvn/diabetes_herbal) has announced the addition of the Diabetes: Herbal Bioactive Molecules Vs. Pharmaceutical Drugs - Volume 1: Cinnamon Global Markets, Competitors And Opportunities - 2014-2019 Analysis And Forecasts report to their offering. Diabetes is a metabolic disorder arising mainly due to the fault in the production of insulin or mounting resistance to its action. In the case of Diabetes, the most serious problem is the side effect, which occurs due to the accumulation of glucose. This excess glucose is converted into various compounds and also into free radicals, which damage the vital organs and organelles. Diabetes was seriously underrated as a threat to global public health until very recently. Today, Diabetes now ranks as one of the greatest public health challenges in the history of mankind. There were 382 million people with Diabetes, or 8.3% of the global population, in 2013. By 2035, this number will be 10.1%, equal almost 600 million people worldwide. Diabetes has a very large economic impact. For example, in the US the cost of diagnosed Diabetes in 2012 is estimated at US$245 billion, including $176 billion in direct medical costs. In 2013, the average Diabetes related expenditures per person in the US was USD9,800. Globally, per capita Diabetes related expenditures in 2013 was USD1,436. Further, the global market for Diabetes medications is estimated at approximately USD45 billion in 2013 and is growing 10.5% annually overall, with insulin sales increasing at a 14.2% CAGR. The currently available antidiabetic drugs manage the blood glucose levels under normal range by supplementing insulin, improving insulin sensitivity, increasing insulin secretion from the pancreas, decreasing glucose absorption from the intestinal tract and/or glucose uptake by tissue cells. Today, the management of Diabetes without any side effect is still a challenge to the medical fraternity. However, a wide array of plant-derived active principles has demonstrated antidiabetic activity. These natural medicines modulate blood sugar levels through a variety of mechanisms. In some cases their effects are similar to conventional medicines. This report looks at the use of medicinal plants, rather than pharmaceutical drugs, to both prevent and treat Diabetes. Specifically, it looks in detail at one of these plants: Cinnamon. Cinnamon is widely used and available and the market for it is well developed. The modern literature indicates that the potential antidiabetic properties of Cinnamon have been studied for over 20 years. Numerous trials have been conducted in humans to determine the metabolic effects of Cinnamon. This report provides: - A detailed look at the Diabetes market including its incidence by country now and during the next 20 years, economic impacts and costs by type, especially medications. - Analysis of medicinal plants to manage Diabetes including experimental studies on the hypoglycaemic activity and bioactive components of 66 plants. - The potential of Cinnamon for the management of Diabetes including its biological effects, molecular mechanisms of action and clinical studies. - Analysis of the global market for Cinnamon including production, imports, exports and traders. Additionally, profiles of 45 leading, public and private companies involved in the Cinnamon industry as producers, distributors, and retailers are given. The report also includes 30 tables and 50 figures. Key Topics Covered: CONTENTS EXECUTIVE SUMMARY INTRODUCTION Background Methodology and Sources Statistical Notes DIABETES MARKET OVERVIEW - Pandemic - Orthodox Approach - Lifestyle Changes - Diet - Nonorthodox Approach: Medicinal Plants - Global Economic Impact Of Diabetes - World Population Of 20-79 Year Olds: 2013-2035 - Diabetes Incidence By Country - Diabetes Prevalence By Country: 2013-2035 - Diabetes-Related Expenditure Per Person By Country: 2013-2035 - Economic Costs Of Diabetes In The US - US Diabetes Costs By Type - Diabetes Medications Company Market Shares - Insulin Is The Final Solution - Insulin Market Growth Drivers - Insulin Market Value Drivers - Insulin Market Growth: 2008-2013 - Insulin Market Growth By Region - Insulin Market Segments (Fast Acting, Premix, Long Acting) - GLP-1 MEDICINAL PLANTS AND DIABETES - Conventional Treatment - Conventional Antidiabetic Drugs - Medicinal Plants: A Safe Tool To Manage DM - Mechanism Of Action In Commonly Used Medicinal Plants - Pharmacologically Screened Insulinomimetic Or Insulin Secretagogues Plant Material And Phytoconstituents - Experimental Studies On Hypoglycaemic Activity And Bioactive Components Of 66 Plants - Acacia arabica - Aegle marmelos - Agrimony eupatoria - Allium sativum - Aloe vera - Annona muricata - Annona squamosa - Asparagus racemosus - Bauhinia variegata - Berberine - Biophytum sensitivum - Boerhaavia diffusa - Bougainvillea spectabilis - Brassica nigra - Caesalpinia bonducella - Caffeine - Camellia sinensis - Capsicum frutescens - Catharanthus roseus - Cinnamon zeylaniucm - Citrullus colocynthis - Coccinia indica - Cornus officinalis - Elephantopus scaber - Enicostemma littorale - Ephedra distachya - Eriobotrya japonica - Euccalyptus globulus - Eugenia jambolana - Ficus bengalensis - Fermented Unsalted Soybeans - Genistein - Ginkgo biloba - Radix glycyrrhizae - Gymnema sylvestre - Helicteres isora - Hibiscus rosa sinensis - Hordeum vulgare - Lepechinia caulescens - Medicago sativa - Momordica charantia - Mucuna pruriens - Nigella sativa oil - Panax ginseng - Pandanus odorus - Parinari excelsa - Prunella vulgaris - Psidium guajava - Pterocarpus marsupium - Radix rehmanniae - Rehmania glutinosa - Ricinus communis - Syzygium cumini - Salvia lavandifolia - Sarcopoterium spinosum - Selaginella tamariscina - Semen coicis - Smallanthus sonchifolius - Stevia rebaudiana - Swertia chirayita - Swertia punicea - Tabernanthe iboga - Teucrium polium - Tinospora crispa - Tribuluks terrestris - Trigonella foenum-graecum - Zizyphus spina-christi - Conclusions - Medicinal Plant Market - Production - Exports - Imports - Trade Balance CINNAMON AND DIABETES - Definition - Genus Cinnamomum - Species - Flavor, Aroma And Taste - History - Early History - Modern History - Agronomy Research And Development Efforts - Cultivation - Grading - Processing - Uses - Adverse Effects - Clinical Potential Of Cinnamon For The Management Of Diabetes - Biological Effects Of Cinnamon - Cinnamon Has Been Studied For Over 20 Years - Molecular Mechanisms Of Action Of Cinnamon - Clinical Studies With Cinnamon - Conclusions CINNAMON MARKET OVERVIEW - Cinnamon Vs. Medicinal Plant Production - Production - Cinnamon Market: 1992-2013 - Cinnamon Market Outlook: 2014-2019 - Cinnamon Exports By Country - Cinnamon Trade Balance By Country - Cinnamon Export And Import Companies COMPANY PROFILES A.A. Sayia & Company, Inc A. Baur & Co (Pvt.) Ltd. ACH Food Companies, Inc. Adam Group Adams Extract & Spice, LLC Ajinomoto Co., Inc. Bart Ingredients Company Ltd Bio Foods Pvt Ltd Bolner's Fiesta Products Ceylon Spice Company C.F. Sauer Company EOAS International Everson Spice Company First Spice Mixing Company Frontier Natural Products Co-op Inc. Goya Foods, Inc. HDDES Group Hong Son Cassia & Star Aniseed Processing Co., Ltd. Horn Company Huong Que Company Indus Organics Integrity Nutraceuticals International Founded Intercom Limited Ishana Spice Exports L B Spices Trading (Private) Limited La Flor Spices La India Packing Company McCormick & Company, Incorporated Monteray Bay Spice Company Mountain Rose Herbs Nature's Agro Products Lanka Company Novo Nordisk A/S Olam International Limited Orient Vietnam Company Limited PT Cassia Co-Op PT Dwiwarna Inti Sejahtera Rathna Producers Cinnamon Exports (Pvt) Ltd. Saboor Chatoor (Private) Limited SC Seasoning Co., Inc. SDS Spices (PVT) Ltd. Spice House USA The Empire Associates Tripper Vanns Spices Whole Foods Market, Inc. Wixon Inc. APPENDIX 1: DIABETES OVERVIEW - Classification - Insulin - Untreated Diabetes - Treated Diabetes - Poor Diagnosis Rates - Type 2 Medications - History - Type 1 Diabetes - Cause - Genetics - Environmental - Diet - Chemicals And Drugs - Pathophysiology - Diagnosis - Tight Glycaemic Control - Autoantibodies - Prevention - Immunosuppressive Drugs - Management - Pancreas Transplantation - Islet Cell Transplantation - Stem Cell Educator Therapy - Depression - Eating Disorders - Complications - Time Of Diagnosis - GAD65 Vaccine - T Helper Cell Shift - Labile Diabetes - Type 2 Diabetes - Signs and Symptoms - Complications - Cause - Lifestyle - Genetics - Medical Conditions - Pathophysiology - Diagnosis - Prevention - Management - Lifestyle - Medications - Surgery - Metabolic Syndrome - History - Definitions And Diagnosis - IDF - WHO - EGIR - NCEP - American Heart Association - Other - Etiology - Pathophysiology - Stress - Overweight And Obesity - Sedentary Lifestyle - Aging - Type 2 Risk - Coronary Heart Disease - Lipodystrophy - Psychiatric Illnesses - Rheumatic Diseases - Signs and Symptoms - Prevention - Therapy - Controversy - Diabetes And Food Prices APPENDIX 2: INSULIN OVERVIEW - Gene - Alleles - Regulation - Protein Structure - Synthesis - Release - Oscillations - Blood Content - Signal Transduction - Effect On Glucose Uptake and Metabolism - Degradation - Hypoglycemia - Diseases And Syndromes - Medication - Discovery - Extraction And Purification - Synthesis - Nobel Prizes - Glucagon-Like Peptide-1 - Physiological Functions - Leptin - Physiology - Function - Adiposity Signal - Interaction With Amylin - Metreleptin TABLES 1.) Global Diabetes Market Summary: 2014-2019 (Diabetes Cases (Million), Diabetes Related Expenditures Per Person (USD), Total Diabetes Related Expenditures (USD Billion), Total Diabetes Medications Demand (USD Billion), Medicinal Plants Production (USD Billion), Cinnamon Production (USD Million) 2.) Population Of 20-79 Year Olds Ranked For The World And 218 Countries Plus Growth Rates: 2013-2035 3.) Diabetes Cases (1000s) Among 20-79 Year Olds Ranked For The World And 218 Countries Plus Growth Rates: 2013-2035 4.) Diabetes National Prevalence (%) Ranked For The World And 218 Countries: 2013-2035 5.) Diabetes-Related Expenditures Per Person With Diabetes For The World And 218 Countries (USD): 2013 6.) US Health Care Expenditures By Diabetes Status And Type Of Service (USD Million): 2012 7.) US Health Care Expenditures Attributed To Diabetes By Age Group And Type Of Service (USD Million): 2012 8.) US Per Capita Health Care Expenditures Attributed To Diabetes By Age Group And Type Of Service (USD Million): 2012 9.) US Health Care Expenditures Attributed To Diabetes By Medical Condition And Type Of Service (USD Million): 2012 10.) US Annual Per Capita Health Care Expenditures By Diabetes Status (Actual Dollars): 2012 11.) Existing Synthetic Drugs For Type 2 DM In Market And Their Molecular Targets, Site Of Action And Adverse Reactions 12.) Commonly Used Conventional And Natural Medicines For Diabetes 13.) List Of Plants Having Antidiabetic Activity 14.) List of Plants Having Insulin Mimetic Or Insulin Secreatory Activity 15.) List Of Plants Phytoconstituents Having Insulin Secretagogues Or Insulin Mimetic Activity 16.) Global Medicinal Plant Exports By Country And Growth Rate (USD Thousands): 2008-2012 17.) Global Medicinal Plant Imports By Country And Growth Rate (USD Thousands): 2008-2012 18.) Global Medicinal Plant Trade Balance By Country And Growth Rate (USD Thousands): 2008-2012 19.) Summary Of Human Studies Where Patients With Type 2 Diabetes, Metabolic Syndrome, Impaired Fasting Glucose And Associated Diseases Were Treated With Cinnamon 20.) Global Medicinal Plant Vs. Cinnamon Production (USD Million): 2014-2019 21.) Global Cinnamon Production By Country (Metric Tons): 1982-2012 22.) Global Cinnamon Market (USD Million, Metric Tons, Average Selling Price): 1992-2013 23.) Global Cinnamon Market (USD Million, Metric Tons, Average Selling Price): 2014-2019 24.) Global Exports Of Cinnamon For World And 121 Countries (USD Thousand): 2008-2012 25.) Global Imports Of Cinnamon For World And 198 Countries (USD Thousand): 2008-2012 26.) Global Trade Balance Of Cinnamon For World And 202 Countries (USD Thousand): 2008-2012 27.) 481 Cinnamon Export Companies By Country (Name, Product/Service Categories Traded, Employees, Country, Website): 2014 28.) 201 Cinnamon Import Companies By Country (Name, Product/Service Categories Traded, Employees, Country, Website): 2014 29.) Comparison Of Type 1 And Type 2 Diabetes 30.) Commonly Prescribed Products For The Treatment Of Type 2 Diabetes FIGURES 1.) Global Diabetes Medications Market By Treatment Class (GLP-1, Insulin, OAD): 2003-2013 2.) Global Diabetes Medications Market Shares By Company (%): 2003-2013 3.) Progression Of Type 2 Diabetes And Treatment Intensification 4.) Distribution Of Patients And Value Across Treatment Classes 5.) Global Insulin Market Growth By Component: 2008-2013 6.) Global Insulin Market: Device Penetration Vs. Modern Insulin Penetration 7.) Global Modern Insulin Volume Company Market Shares 8.) Insulin Market Size And Growth By Region, Volume Composition, Volume Market Shares By Company: 2012-2013 9.) Regional (North America, Europe, China, Japan, Korea) Insulin Market Volume Growth Rates: 2003-2013 10.) Regional (North America, Europe, China, Japan, Korea) Insulin Volume Market Split: 2003-2013 11.) Action Profiles Of Insulins By Type 12.) Global Insulin Market Volume And Growth By Segment: 2008-2013 13.) Global GLP-1 Market Value And Market Share: 2008-2013 14.) GLP-1 Market By Region (%): 2013 15.) US GLP-1 Market-Victoza Vs. Other GLP-1(Value, TRx Scripts, % of Diabetes Care): 2010-2013 16.) Germany, UK And France Markets for GLP-1: Victoza Vs. Other GLP-1 Products (Value, % of Diabetes Care): 2009-2013 17.) Effects Of Phytochemicals in Insulin Secretion And Pancreatic--cell Apoptosis 18.) Cinnamomum verum 19.) Cinnamon Trees 20.) Cinnamon Products 21.) Flow Diagram Of Cinnamon Processing 22.) Mechanisms Of Action Of Cinnamon In Relevant Metabolic Pathways 23.) Novo Nordisk Diabetes Care Revenues By Segment (DKK Billion): 2013 24.) Novo Nordisk MAT Diabetes Care Sales Growth By Segment (%): 2008-2013 25.) Novo Nordisk Global And Regional Insulin Market Shares: 2013 26.) Novo Nordisk Revenue And Growth By Product and Region: 2009-2013 27.) Novo Nordisk Volume Market Share Across Insulin Classes 28.) Novo Nordisk Brand Names, Product Types, Sales, Market Shares, Patent Expirations: 2013 29.) Novo Nordisk's Modern Insulins Volume Market Share By Segment 30.) Novo Nordisk Product Growth And Market Shares By Segment: 2008-2013 31.) Novo Nordisk Modern Insulin US Market Share By Market Segment: 2008-2013 32.) US Insulin Supplier Volume Market Shares (%): 2013 33.) European Insulin Supplier Volume Market Shares (%): 2013 34.) Chinese Insulin Supplier Volume Market Shares (%): 2013 35.) Japanese Insulin Supplier Volume Market Shares (%): 2013 36.) Novo Nordisk Current And Future Product Portfolio 37.) Novo Nordisk R&D Pipeline: Diabetes And Obesity 38.) Insulin Secretion Profile 39.) Insulin Enables Glucose To Become Energy 40.) Insulin Level Vs. Time Of Day 41.) Diabetes Diagnosis And The Rule Of Halves 42.) Glycaemic Control In Selected Countries (%) 43.) Diabetes Prevalence And Diagnosis Rates By Region: 2013 44.) Main Symptoms of Diabetes 45.) Risk Reduction By Class From Lowering HbA1c By 1%-Point 46.) Insulin Synthesis Process 47.) Insulin Oscillations 48.) Idealized Diagram Of Blood Sugar Fluctuation 49.) Effect Of Insulin On Glucose Uptake And Metabolism 50.) The Structure Of Insulin Companies Mentioned: - A. Baur & Co (Pvt.) Ltd. - A.A. Sayia & Company, Inc - ACH Food Companies, Inc. - Adam Group - Adams Extract & Spice, LLC - Ajinomoto Co., Inc. - Bart Ingredients Company Ltd - Bio Foods Pvt Ltd - Bolner's Fiesta Products - C.F. Sauer Company - Ceylon Spice Company - EOAS International - Everson Spice Company - First Spice Mixing Company - Frontier Natural Products Co-op Inc. - Goya Foods, Inc. - HDDES Group - Hong Son Cassia & Star Aniseed Processing Co., Ltd. - Horn Company - Huong Que Company - Indus Organics - Integrity Nutraceuticals International Founded - Intercom Limited - Ishana Spice Exports - L B Spices Trading (Private) Limited - La Flor Spices - La India Packing Company - McCormick & Company, Incorporated - Monteray Bay Spice Company - Mountain Rose Herbs - Nature's Agro Products Lanka Company - Novo Nordisk A/S - Olam International Limited - Orient Vietnam Company Limited - PT Cassia Co-Op - PT Dwiwarna Inti Sejahtera - Rathna Producers Cinnamon Exports (Pvt) Ltd. - SC Seasoning Co., Inc. - SDS Spices (PVT) Ltd. - Saboor Chatoor (Private) Limited - Spice House USA - The Empire Associates - Tripper - Vanns Spices - Whole Foods Market, Inc. - Wixon Inc. For more information visit http://www.researchandmarkets.com/research/b4...tes_herbal About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
3 New Ways to Get Your Probiotic Fix: Fresh Kefir Creations from Lifeway Foods
PR Newswire - Fri Mar 07, 11:00AM CST
Looking for new ways to get your daily dose of immunity-building probiotics? Top kefir manufacturer Lifeway Foods, Inc. (NASDAQ: LWAY) has developed three new varieties of its dairy-based kefir "smoothie" that deliver a trio of fresh choices for drinking to your health. The new veggie, oat-enriched and stevia-sweetened kefir lines will be released this spring in 10 flavors created specifically for the new formulations - the better to start your day, have a guilt-free snack, or add a probiotic boost to any meal.
Nuvilex Inc. to Work with Leading Figure in Pancreatic Cancer
ACCESSWIRE - Fri Mar 07, 8:00AM CST
Nuvilex, Inc.'s (OTCQB: NVLX) stock volume continued to soar Apr. 3, with 25,542,125 shares changing hands, nearly double its three-month average volume of 12,823,479 shares.
Stevia Corp. Registers Wholly Owned US Subsidiary, Real Hemp LLC
Marketwire - Wed Mar 05, 8:02AM CST
Stevia Corp. (OTCQB: STEV) ("Stevia Corp" or the "Company" , a farm management company focused on the economic development of products that support a healthy lifestyle, including stevia and hemp, is pleased to announce the Company has registered a wholly owned subsidiary, Real Hemp LLC, an Indiana limited liability company. In addition, the Company has filed a federal trademark registration for "Real Hemp" and secured the "RealHemp.com" domain as part of its strategy to enter the US hemp industry and become a leading importer, manufacturer and licensor of hemp products and hemp derivatives.
Stevia Corp. Announces Entry Into Securities Purchase Agreement and Senior Convertible Note With an Institutional Investor
Marketwire - Tue Mar 04, 8:03AM CST
Stevia Corp. (OTCQB: STEV) ("Stevia Corp" or the "Company" , a farm management company focused on the economic development of products that support a healthy lifestyle, including stevia and hemp, is pleased to announce that effective March 3, 2014 (the "Closing Date" , it has entered into a definitive securities purchase agreement with an institutional investor to raise $940,000.
Stevia Corp. Signs Consulting Agreement for Identification and Extraction of Cannabinoids From Cannabis
Marketwire - Wed Feb 26, 6:45AM CST
Stevia Corp. (OTCQB: STEV) ("Stevia Corp" or the "Company" , a farm management company focused on the economic development of products that support a healthy lifestyle, including stevia and hemp, is pleased to announce the signing of a farm management and technology agreement with ebbu LLC ("ebbu" of Arvada, Colorado.
Stevia Corp. Enters Hemp Industry as the United States Farm Bill Changes the U.S. Legislative Position on Hemp
Marketwire - Thu Feb 20, 9:52AM CST
Stevia Corp. (OTCQB: STEV) ("Stevia Corp" or the "Company" , a farm management company focused on the economic development of products that support healthy lifestyle, is pleased to offer insights regarding key aspects of planned expansions.
Stevia First Discovers Novel Plant Variant in Extensive Field Trials
Marketwire - Tue Feb 18, 8:03AM CST
Stevia First Corp. (OTCQB: STVF) ("Stevia First" or the "Company" , an early-stage agribusiness based in California's Central Valley growing region and focused on the industrial scale production of stevia, the all-natural zero-calorie sweetener that is rapidly transforming the food and beverage industry, is pleased to advise that it has recently identified a novel plant variant through its stevia field trials. The new plant is expected to be useful for discovery and production of rare, next-generation stevia sweeteners, and also for further characterization of key stevia enzymes.
Enbridge Announces Executive Appointments
Marketwire - Fri Feb 14, 6:51AM CST
Enbridge Inc. (TSX: ENB)(NYSE: ENB) and Enbridge Pipelines Inc. announced today changes to responsibilities of certain senior executives, effective March 1, 2014. Stephen J. Wuori, currently President, Liquids Pipelines & Major Projects, will be appointed Strategic Advisor, Office of the President and CEO. Guy Jarvis, currently Executive Vice President and Chief Commercial Officer, Liquids Pipelines, will be appointed President, Liquids Pipelines, reporting to Al Monaco, President and CEO. Concurrent with this appointment, Mr. Jarvis will also assume the role of President, Enbridge Pipelines Inc.
Sweet Green Fields Granted Product Patent for Highest Purity Stevia Extract
PR Newswire - Tue Feb 04, 9:27PM CST
Sweet Green Fields (SGF), the leading U.S. science based, natural sweetener innovator, today announced it was granted a product patent (regardless of manufacturing process) by the Canadian Intellectual Property Office (CIPO) for Rebaudioside A (Reb A) products greater than 98.6 percent purity.
Wisdom Natural Brands to Help Kids Learn Healthy Habits
PRWeb - Fri Jan 31, 1:03AM CST
SweetLeaf Stevia(R) Sweetener announces a partnership with Phoenix-based Project Million to help educate schoolchildren about the importance of healthy eating. SweetLeaf provided Project Million founder Matthew Landen with SweetLeaf(R) Liquid Stevia Sweet Drops™, which will be included in presentations to Paradise Valley students on how to replace sugar and artificial sweeteners in their diets.
Stevia Corp. on Track to Produce Record Harvest
Marketwire - Wed Jan 22, 9:57AM CST
Stevia Corp. (OTCQB: STEV) ("Stevia Corp" or the "Company" , a farm management company focused on the economic development of stevia, the fastest growing product in the alternative sweetener sector, is pleased to provide an update regarding its current crop status and growth opportunities for its fiscal year 2014.
Stevia First Corp - "An "Unstoppable Rise of Stevia" Has Been Reported - The Industry Buzz Makes News"
ACCESSWIRE - Tue Jan 21, 10:12AM CST
Stevia First Corp's (OTCQB: STVF) CEO, Robert Brooke, published a new blog post today on The Chairman's Blog about the rise of enthusiasm and interest in stevia. TheChairmansBlog.com is an exclusive online media publication that provides key executive officers and key opinion leaders a unique platform to share insights about company and industry trends.
Stand Up Pouches Delivers Sweet Results for Steviva Products
PRWeb - Thu Jan 16, 2:53AM CST
Pouch packing supplier, StandUpPouches.net, recently released a branded eBook for Steviva Brands, Inc.—an Oregon-based manufacturer of stevia products and other bulk ingredient sweetners. Titled Stevia Packaging Uses Stand Up Pouches, the eBook profiles stevia's growing popularity among consumers (thanks to its calorie-free, diabetic-friendly, all-natural composition).
Pure Via(R) Using Only Non-GMO Ingredients
Business Wire - Mon Jan 13, 12:55PM CST
Whole Earth Sweetener Company LLC today announced that it has launched a new Pure Via(R) produced with Non-GMO ingredients. Pure Via(R) is the first global brand of all-natural sweetener to promote this choice in the United States. The change affects both Pure Via(R) and Pure Via(R) Turbinado Raw Cane Sugar & Stevia Blend.
NMA Calls EPA's Power Plant Rule a Reckless Gamble with the Economy
PR Newswire - Tue Jan 07, 11:05AM CST
National Mining Association (NMA) President and CEO Hal Quinn issued the following statement in advance of the publication of the Environmental Protection Agency's (EPA) proposed New Source Performance Standard for regulating greenhouse gas emissions from new coal-based power plants that generate 40 percent of the nation's electricity:
TRAUB Completes Strategic Partnership between "In the Soup" and Stevia Corp.
Business Wire - Wed Apr 09, 8:02AM CDT
TRAUB's Consumer Food and Beverage division has arranged for a strategic partnership between "In The Soup," a Colorado based company with a line of Natural and Organic Premium Soups, with Stevia Corp, the international farm management company focused on the development of products that support a healthy lifestyle.
Stevia Corp. Enters Strategic Partnership With 'In The Soup' and TRAUB's Consumer Food and Beverage Group
Marketwire - Tue Apr 08, 7:41AM CDT
Stevia Corp. (OTCQB: STEV) ("Stevia Corp" or the "Company"
, an international farm management company focused on the economic development of products that support a healthy lifestyle, including stevia and hemp, is pleased to announce the Company has entered into a convertible note financing agreement with YOPCP, LLC, a Colorado based manufacturer of 'In The Soup,' a line of Natural and Organic Premium Soups sold in classic glass jars. G. Willi-Food Announces its Entrance into the Soft Drinks Market as it Becomes the First Israeli Distributor of Stevia Sweetened Cola
PR Newswire - Wed Apr 02, 12:10PM CDT
ï"
Sugar Substitute Market by Types (HFS, HIS & LIS) Worth $13.7 Billion by 2018 - New Report by MarketsandMarkets
PRWeb - Tue Mar 18, 8:47AM CDT
The report "Sugar Substitute Market - By Types (HFS, HIS & LIS), Subtypes (Stevia, Sorbitol, Tagatose, Aspartame, Saccharine, Sucralose, Xylitol & Others) & Applications (Healthcare & Personal Care, Beverage & Food) - Global Trends, Forecasts to 2018" defines and segments the global sugar substitute market with analysis of current demand and forecasted consumption in terms of volume and revenue.
Diabetes: Herbal Bioactive Molecules Vs. Pharmaceutical Drugs - Volume 1: Cinnamon Global Markets, Competitors And Opportunities - 2014-2019 Analysis And Forecasts
M2 - Fri Mar 14, 10:38AM CDT
Research and Markets (http://www.researchandmarkets.com/research/b4bhvn/diabetes_herbal) has announced the addition of the Diabetes: Herbal Bioactive Molecules Vs. Pharmaceutical Drugs - Volume 1: Cinnamon Global Markets, Competitors And Opportunities - 2014-2019 Analysis And Forecasts report to their offering. Diabetes is a metabolic disorder arising mainly due to the fault in the production of insulin or mounting resistance to its action. In the case of Diabetes, the most serious problem is the side effect, which occurs due to the accumulation of glucose. This excess glucose is converted into various compounds and also into free radicals, which damage the vital organs and organelles. Diabetes was seriously underrated as a threat to global public health until very recently. Today, Diabetes now ranks as one of the greatest public health challenges in the history of mankind. There were 382 million people with Diabetes, or 8.3% of the global population, in 2013. By 2035, this number will be 10.1%, equal almost 600 million people worldwide. Diabetes has a very large economic impact. For example, in the US the cost of diagnosed Diabetes in 2012 is estimated at US$245 billion, including $176 billion in direct medical costs. In 2013, the average Diabetes related expenditures per person in the US was USD9,800. Globally, per capita Diabetes related expenditures in 2013 was USD1,436. Further, the global market for Diabetes medications is estimated at approximately USD45 billion in 2013 and is growing 10.5% annually overall, with insulin sales increasing at a 14.2% CAGR. The currently available antidiabetic drugs manage the blood glucose levels under normal range by supplementing insulin, improving insulin sensitivity, increasing insulin secretion from the pancreas, decreasing glucose absorption from the intestinal tract and/or glucose uptake by tissue cells. Today, the management of Diabetes without any side effect is still a challenge to the medical fraternity. However, a wide array of plant-derived active principles has demonstrated antidiabetic activity. These natural medicines modulate blood sugar levels through a variety of mechanisms. In some cases their effects are similar to conventional medicines. This report looks at the use of medicinal plants, rather than pharmaceutical drugs, to both prevent and treat Diabetes. Specifically, it looks in detail at one of these plants: Cinnamon. Cinnamon is widely used and available and the market for it is well developed. The modern literature indicates that the potential antidiabetic properties of Cinnamon have been studied for over 20 years. Numerous trials have been conducted in humans to determine the metabolic effects of Cinnamon. This report provides: - A detailed look at the Diabetes market including its incidence by country now and during the next 20 years, economic impacts and costs by type, especially medications. - Analysis of medicinal plants to manage Diabetes including experimental studies on the hypoglycaemic activity and bioactive components of 66 plants. - The potential of Cinnamon for the management of Diabetes including its biological effects, molecular mechanisms of action and clinical studies. - Analysis of the global market for Cinnamon including production, imports, exports and traders. Additionally, profiles of 45 leading, public and private companies involved in the Cinnamon industry as producers, distributors, and retailers are given. The report also includes 30 tables and 50 figures. Key Topics Covered: CONTENTS EXECUTIVE SUMMARY INTRODUCTION Background Methodology and Sources Statistical Notes DIABETES MARKET OVERVIEW - Pandemic - Orthodox Approach - Lifestyle Changes - Diet - Nonorthodox Approach: Medicinal Plants - Global Economic Impact Of Diabetes - World Population Of 20-79 Year Olds: 2013-2035 - Diabetes Incidence By Country - Diabetes Prevalence By Country: 2013-2035 - Diabetes-Related Expenditure Per Person By Country: 2013-2035 - Economic Costs Of Diabetes In The US - US Diabetes Costs By Type - Diabetes Medications Company Market Shares - Insulin Is The Final Solution - Insulin Market Growth Drivers - Insulin Market Value Drivers - Insulin Market Growth: 2008-2013 - Insulin Market Growth By Region - Insulin Market Segments (Fast Acting, Premix, Long Acting) - GLP-1 MEDICINAL PLANTS AND DIABETES - Conventional Treatment - Conventional Antidiabetic Drugs - Medicinal Plants: A Safe Tool To Manage DM - Mechanism Of Action In Commonly Used Medicinal Plants - Pharmacologically Screened Insulinomimetic Or Insulin Secretagogues Plant Material And Phytoconstituents - Experimental Studies On Hypoglycaemic Activity And Bioactive Components Of 66 Plants - Acacia arabica - Aegle marmelos - Agrimony eupatoria - Allium sativum - Aloe vera - Annona muricata - Annona squamosa - Asparagus racemosus - Bauhinia variegata - Berberine - Biophytum sensitivum - Boerhaavia diffusa - Bougainvillea spectabilis - Brassica nigra - Caesalpinia bonducella - Caffeine - Camellia sinensis - Capsicum frutescens - Catharanthus roseus - Cinnamon zeylaniucm - Citrullus colocynthis - Coccinia indica - Cornus officinalis - Elephantopus scaber - Enicostemma littorale - Ephedra distachya - Eriobotrya japonica - Euccalyptus globulus - Eugenia jambolana - Ficus bengalensis - Fermented Unsalted Soybeans - Genistein - Ginkgo biloba - Radix glycyrrhizae - Gymnema sylvestre - Helicteres isora - Hibiscus rosa sinensis - Hordeum vulgare - Lepechinia caulescens - Medicago sativa - Momordica charantia - Mucuna pruriens - Nigella sativa oil - Panax ginseng - Pandanus odorus - Parinari excelsa - Prunella vulgaris - Psidium guajava - Pterocarpus marsupium - Radix rehmanniae - Rehmania glutinosa - Ricinus communis - Syzygium cumini - Salvia lavandifolia - Sarcopoterium spinosum - Selaginella tamariscina - Semen coicis - Smallanthus sonchifolius - Stevia rebaudiana - Swertia chirayita - Swertia punicea - Tabernanthe iboga - Teucrium polium - Tinospora crispa - Tribuluks terrestris - Trigonella foenum-graecum - Zizyphus spina-christi - Conclusions - Medicinal Plant Market - Production - Exports - Imports - Trade Balance CINNAMON AND DIABETES - Definition - Genus Cinnamomum - Species - Flavor, Aroma And Taste - History - Early History - Modern History - Agronomy Research And Development Efforts - Cultivation - Grading - Processing - Uses - Adverse Effects - Clinical Potential Of Cinnamon For The Management Of Diabetes - Biological Effects Of Cinnamon - Cinnamon Has Been Studied For Over 20 Years - Molecular Mechanisms Of Action Of Cinnamon - Clinical Studies With Cinnamon - Conclusions CINNAMON MARKET OVERVIEW - Cinnamon Vs. Medicinal Plant Production - Production - Cinnamon Market: 1992-2013 - Cinnamon Market Outlook: 2014-2019 - Cinnamon Exports By Country - Cinnamon Trade Balance By Country - Cinnamon Export And Import Companies COMPANY PROFILES A.A. Sayia & Company, Inc A. Baur & Co (Pvt.) Ltd. ACH Food Companies, Inc. Adam Group Adams Extract & Spice, LLC Ajinomoto Co., Inc. Bart Ingredients Company Ltd Bio Foods Pvt Ltd Bolner's Fiesta Products Ceylon Spice Company C.F. Sauer Company EOAS International Everson Spice Company First Spice Mixing Company Frontier Natural Products Co-op Inc. Goya Foods, Inc. HDDES Group Hong Son Cassia & Star Aniseed Processing Co., Ltd. Horn Company Huong Que Company Indus Organics Integrity Nutraceuticals International Founded Intercom Limited Ishana Spice Exports L B Spices Trading (Private) Limited La Flor Spices La India Packing Company McCormick & Company, Incorporated Monteray Bay Spice Company Mountain Rose Herbs Nature's Agro Products Lanka Company Novo Nordisk A/S Olam International Limited Orient Vietnam Company Limited PT Cassia Co-Op PT Dwiwarna Inti Sejahtera Rathna Producers Cinnamon Exports (Pvt) Ltd. Saboor Chatoor (Private) Limited SC Seasoning Co., Inc. SDS Spices (PVT) Ltd. Spice House USA The Empire Associates Tripper Vanns Spices Whole Foods Market, Inc. Wixon Inc. APPENDIX 1: DIABETES OVERVIEW - Classification - Insulin - Untreated Diabetes - Treated Diabetes - Poor Diagnosis Rates - Type 2 Medications - History - Type 1 Diabetes - Cause - Genetics - Environmental - Diet - Chemicals And Drugs - Pathophysiology - Diagnosis - Tight Glycaemic Control - Autoantibodies - Prevention - Immunosuppressive Drugs - Management - Pancreas Transplantation - Islet Cell Transplantation - Stem Cell Educator Therapy - Depression - Eating Disorders - Complications - Time Of Diagnosis - GAD65 Vaccine - T Helper Cell Shift - Labile Diabetes - Type 2 Diabetes - Signs and Symptoms - Complications - Cause - Lifestyle - Genetics - Medical Conditions - Pathophysiology - Diagnosis - Prevention - Management - Lifestyle - Medications - Surgery - Metabolic Syndrome - History - Definitions And Diagnosis - IDF - WHO - EGIR - NCEP - American Heart Association - Other - Etiology - Pathophysiology - Stress - Overweight And Obesity - Sedentary Lifestyle - Aging - Type 2 Risk - Coronary Heart Disease - Lipodystrophy - Psychiatric Illnesses - Rheumatic Diseases - Signs and Symptoms - Prevention - Therapy - Controversy - Diabetes And Food Prices APPENDIX 2: INSULIN OVERVIEW - Gene - Alleles - Regulation - Protein Structure - Synthesis - Release - Oscillations - Blood Content - Signal Transduction - Effect On Glucose Uptake and Metabolism - Degradation - Hypoglycemia - Diseases And Syndromes - Medication - Discovery - Extraction And Purification - Synthesis - Nobel Prizes - Glucagon-Like Peptide-1 - Physiological Functions - Leptin - Physiology - Function - Adiposity Signal - Interaction With Amylin - Metreleptin TABLES 1.) Global Diabetes Market Summary: 2014-2019 (Diabetes Cases (Million), Diabetes Related Expenditures Per Person (USD), Total Diabetes Related Expenditures (USD Billion), Total Diabetes Medications Demand (USD Billion), Medicinal Plants Production (USD Billion), Cinnamon Production (USD Million) 2.) Population Of 20-79 Year Olds Ranked For The World And 218 Countries Plus Growth Rates: 2013-2035 3.) Diabetes Cases (1000s) Among 20-79 Year Olds Ranked For The World And 218 Countries Plus Growth Rates: 2013-2035 4.) Diabetes National Prevalence (%) Ranked For The World And 218 Countries: 2013-2035 5.) Diabetes-Related Expenditures Per Person With Diabetes For The World And 218 Countries (USD): 2013 6.) US Health Care Expenditures By Diabetes Status And Type Of Service (USD Million): 2012 7.) US Health Care Expenditures Attributed To Diabetes By Age Group And Type Of Service (USD Million): 2012 8.) US Per Capita Health Care Expenditures Attributed To Diabetes By Age Group And Type Of Service (USD Million): 2012 9.) US Health Care Expenditures Attributed To Diabetes By Medical Condition And Type Of Service (USD Million): 2012 10.) US Annual Per Capita Health Care Expenditures By Diabetes Status (Actual Dollars): 2012 11.) Existing Synthetic Drugs For Type 2 DM In Market And Their Molecular Targets, Site Of Action And Adverse Reactions 12.) Commonly Used Conventional And Natural Medicines For Diabetes 13.) List Of Plants Having Antidiabetic Activity 14.) List of Plants Having Insulin Mimetic Or Insulin Secreatory Activity 15.) List Of Plants Phytoconstituents Having Insulin Secretagogues Or Insulin Mimetic Activity 16.) Global Medicinal Plant Exports By Country And Growth Rate (USD Thousands): 2008-2012 17.) Global Medicinal Plant Imports By Country And Growth Rate (USD Thousands): 2008-2012 18.) Global Medicinal Plant Trade Balance By Country And Growth Rate (USD Thousands): 2008-2012 19.) Summary Of Human Studies Where Patients With Type 2 Diabetes, Metabolic Syndrome, Impaired Fasting Glucose And Associated Diseases Were Treated With Cinnamon 20.) Global Medicinal Plant Vs. Cinnamon Production (USD Million): 2014-2019 21.) Global Cinnamon Production By Country (Metric Tons): 1982-2012 22.) Global Cinnamon Market (USD Million, Metric Tons, Average Selling Price): 1992-2013 23.) Global Cinnamon Market (USD Million, Metric Tons, Average Selling Price): 2014-2019 24.) Global Exports Of Cinnamon For World And 121 Countries (USD Thousand): 2008-2012 25.) Global Imports Of Cinnamon For World And 198 Countries (USD Thousand): 2008-2012 26.) Global Trade Balance Of Cinnamon For World And 202 Countries (USD Thousand): 2008-2012 27.) 481 Cinnamon Export Companies By Country (Name, Product/Service Categories Traded, Employees, Country, Website): 2014 28.) 201 Cinnamon Import Companies By Country (Name, Product/Service Categories Traded, Employees, Country, Website): 2014 29.) Comparison Of Type 1 And Type 2 Diabetes 30.) Commonly Prescribed Products For The Treatment Of Type 2 Diabetes FIGURES 1.) Global Diabetes Medications Market By Treatment Class (GLP-1, Insulin, OAD): 2003-2013 2.) Global Diabetes Medications Market Shares By Company (%): 2003-2013 3.) Progression Of Type 2 Diabetes And Treatment Intensification 4.) Distribution Of Patients And Value Across Treatment Classes 5.) Global Insulin Market Growth By Component: 2008-2013 6.) Global Insulin Market: Device Penetration Vs. Modern Insulin Penetration 7.) Global Modern Insulin Volume Company Market Shares 8.) Insulin Market Size And Growth By Region, Volume Composition, Volume Market Shares By Company: 2012-2013 9.) Regional (North America, Europe, China, Japan, Korea) Insulin Market Volume Growth Rates: 2003-2013 10.) Regional (North America, Europe, China, Japan, Korea) Insulin Volume Market Split: 2003-2013 11.) Action Profiles Of Insulins By Type 12.) Global Insulin Market Volume And Growth By Segment: 2008-2013 13.) Global GLP-1 Market Value And Market Share: 2008-2013 14.) GLP-1 Market By Region (%): 2013 15.) US GLP-1 Market-Victoza Vs. Other GLP-1(Value, TRx Scripts, % of Diabetes Care): 2010-2013 16.) Germany, UK And France Markets for GLP-1: Victoza Vs. Other GLP-1 Products (Value, % of Diabetes Care): 2009-2013 17.) Effects Of Phytochemicals in Insulin Secretion And Pancreatic--cell Apoptosis 18.) Cinnamomum verum 19.) Cinnamon Trees 20.) Cinnamon Products 21.) Flow Diagram Of Cinnamon Processing 22.) Mechanisms Of Action Of Cinnamon In Relevant Metabolic Pathways 23.) Novo Nordisk Diabetes Care Revenues By Segment (DKK Billion): 2013 24.) Novo Nordisk MAT Diabetes Care Sales Growth By Segment (%): 2008-2013 25.) Novo Nordisk Global And Regional Insulin Market Shares: 2013 26.) Novo Nordisk Revenue And Growth By Product and Region: 2009-2013 27.) Novo Nordisk Volume Market Share Across Insulin Classes 28.) Novo Nordisk Brand Names, Product Types, Sales, Market Shares, Patent Expirations: 2013 29.) Novo Nordisk's Modern Insulins Volume Market Share By Segment 30.) Novo Nordisk Product Growth And Market Shares By Segment: 2008-2013 31.) Novo Nordisk Modern Insulin US Market Share By Market Segment: 2008-2013 32.) US Insulin Supplier Volume Market Shares (%): 2013 33.) European Insulin Supplier Volume Market Shares (%): 2013 34.) Chinese Insulin Supplier Volume Market Shares (%): 2013 35.) Japanese Insulin Supplier Volume Market Shares (%): 2013 36.) Novo Nordisk Current And Future Product Portfolio 37.) Novo Nordisk R&D Pipeline: Diabetes And Obesity 38.) Insulin Secretion Profile 39.) Insulin Enables Glucose To Become Energy 40.) Insulin Level Vs. Time Of Day 41.) Diabetes Diagnosis And The Rule Of Halves 42.) Glycaemic Control In Selected Countries (%) 43.) Diabetes Prevalence And Diagnosis Rates By Region: 2013 44.) Main Symptoms of Diabetes 45.) Risk Reduction By Class From Lowering HbA1c By 1%-Point 46.) Insulin Synthesis Process 47.) Insulin Oscillations 48.) Idealized Diagram Of Blood Sugar Fluctuation 49.) Effect Of Insulin On Glucose Uptake And Metabolism 50.) The Structure Of Insulin Companies Mentioned: - A. Baur & Co (Pvt.) Ltd. - A.A. Sayia & Company, Inc - ACH Food Companies, Inc. - Adam Group - Adams Extract & Spice, LLC - Ajinomoto Co., Inc. - Bart Ingredients Company Ltd - Bio Foods Pvt Ltd - Bolner's Fiesta Products - C.F. Sauer Company - Ceylon Spice Company - EOAS International - Everson Spice Company - First Spice Mixing Company - Frontier Natural Products Co-op Inc. - Goya Foods, Inc. - HDDES Group - Hong Son Cassia & Star Aniseed Processing Co., Ltd. - Horn Company - Huong Que Company - Indus Organics - Integrity Nutraceuticals International Founded - Intercom Limited - Ishana Spice Exports - L B Spices Trading (Private) Limited - La Flor Spices - La India Packing Company - McCormick & Company, Incorporated - Monteray Bay Spice Company - Mountain Rose Herbs - Nature's Agro Products Lanka Company - Novo Nordisk A/S - Olam International Limited - Orient Vietnam Company Limited - PT Cassia Co-Op - PT Dwiwarna Inti Sejahtera - Rathna Producers Cinnamon Exports (Pvt) Ltd. - SC Seasoning Co., Inc. - SDS Spices (PVT) Ltd. - Saboor Chatoor (Private) Limited - Spice House USA - The Empire Associates - Tripper - Vanns Spices - Whole Foods Market, Inc. - Wixon Inc. For more information visit http://www.researchandmarkets.com/research/b4...tes_herbal About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
3 New Ways to Get Your Probiotic Fix: Fresh Kefir Creations from Lifeway Foods
PR Newswire - Fri Mar 07, 11:00AM CST
Looking for new ways to get your daily dose of immunity-building probiotics? Top kefir manufacturer Lifeway Foods, Inc. (NASDAQ: LWAY) has developed three new varieties of its dairy-based kefir "smoothie" that deliver a trio of fresh choices for drinking to your health. The new veggie, oat-enriched and stevia-sweetened kefir lines will be released this spring in 10 flavors created specifically for the new formulations - the better to start your day, have a guilt-free snack, or add a probiotic boost to any meal.
Nuvilex Inc. to Work with Leading Figure in Pancreatic Cancer
ACCESSWIRE - Fri Mar 07, 8:00AM CST
Nuvilex, Inc.'s (OTCQB: NVLX) stock volume continued to soar Apr. 3, with 25,542,125 shares changing hands, nearly double its three-month average volume of 12,823,479 shares.
Stevia Corp. Registers Wholly Owned US Subsidiary, Real Hemp LLC
Marketwire - Wed Mar 05, 8:02AM CST
Stevia Corp. (OTCQB: STEV) ("Stevia Corp" or the "Company"
, a farm management company focused on the economic development of products that support a healthy lifestyle, including stevia and hemp, is pleased to announce the Company has registered a wholly owned subsidiary, Real Hemp LLC, an Indiana limited liability company. In addition, the Company has filed a federal trademark registration for "Real Hemp" and secured the "RealHemp.com" domain as part of its strategy to enter the US hemp industry and become a leading importer, manufacturer and licensor of hemp products and hemp derivatives. Stevia Corp. Announces Entry Into Securities Purchase Agreement and Senior Convertible Note With an Institutional Investor
Marketwire - Tue Mar 04, 8:03AM CST
Stevia Corp. (OTCQB: STEV) ("Stevia Corp" or the "Company"
, a farm management company focused on the economic development of products that support a healthy lifestyle, including stevia and hemp, is pleased to announce that effective March 3, 2014 (the "Closing Date" , it has entered into a definitive securities purchase agreement with an institutional investor to raise $940,000. Stevia Corp. Signs Consulting Agreement for Identification and Extraction of Cannabinoids From Cannabis
Marketwire - Wed Feb 26, 6:45AM CST
Stevia Corp. (OTCQB: STEV) ("Stevia Corp" or the "Company"
, a farm management company focused on the economic development of products that support a healthy lifestyle, including stevia and hemp, is pleased to announce the signing of a farm management and technology agreement with ebbu LLC ("ebbu" of Arvada, Colorado. Stevia Corp. Enters Hemp Industry as the United States Farm Bill Changes the U.S. Legislative Position on Hemp
Marketwire - Thu Feb 20, 9:52AM CST
Stevia Corp. (OTCQB: STEV) ("Stevia Corp" or the "Company"
, a farm management company focused on the economic development of products that support healthy lifestyle, is pleased to offer insights regarding key aspects of planned expansions. Stevia First Discovers Novel Plant Variant in Extensive Field Trials
Marketwire - Tue Feb 18, 8:03AM CST
Stevia First Corp. (OTCQB: STVF) ("Stevia First" or the "Company"
, an early-stage agribusiness based in California's Central Valley growing region and focused on the industrial scale production of stevia, the all-natural zero-calorie sweetener that is rapidly transforming the food and beverage industry, is pleased to advise that it has recently identified a novel plant variant through its stevia field trials. The new plant is expected to be useful for discovery and production of rare, next-generation stevia sweeteners, and also for further characterization of key stevia enzymes. Enbridge Announces Executive Appointments
Marketwire - Fri Feb 14, 6:51AM CST
Enbridge Inc. (TSX: ENB)(NYSE: ENB) and Enbridge Pipelines Inc. announced today changes to responsibilities of certain senior executives, effective March 1, 2014. Stephen J. Wuori, currently President, Liquids Pipelines & Major Projects, will be appointed Strategic Advisor, Office of the President and CEO. Guy Jarvis, currently Executive Vice President and Chief Commercial Officer, Liquids Pipelines, will be appointed President, Liquids Pipelines, reporting to Al Monaco, President and CEO. Concurrent with this appointment, Mr. Jarvis will also assume the role of President, Enbridge Pipelines Inc.
Sweet Green Fields Granted Product Patent for Highest Purity Stevia Extract
PR Newswire - Tue Feb 04, 9:27PM CST
Sweet Green Fields (SGF), the leading U.S. science based, natural sweetener innovator, today announced it was granted a product patent (regardless of manufacturing process) by the Canadian Intellectual Property Office (CIPO) for Rebaudioside A (Reb A) products greater than 98.6 percent purity.
Wisdom Natural Brands to Help Kids Learn Healthy Habits
PRWeb - Fri Jan 31, 1:03AM CST
SweetLeaf Stevia(R) Sweetener announces a partnership with Phoenix-based Project Million to help educate schoolchildren about the importance of healthy eating. SweetLeaf provided Project Million founder Matthew Landen with SweetLeaf(R) Liquid Stevia Sweet Drops™, which will be included in presentations to Paradise Valley students on how to replace sugar and artificial sweeteners in their diets.
Stevia Corp. on Track to Produce Record Harvest
Marketwire - Wed Jan 22, 9:57AM CST
Stevia Corp. (OTCQB: STEV) ("Stevia Corp" or the "Company"
, a farm management company focused on the economic development of stevia, the fastest growing product in the alternative sweetener sector, is pleased to provide an update regarding its current crop status and growth opportunities for its fiscal year 2014. Stevia First Corp - "An "Unstoppable Rise of Stevia" Has Been Reported - The Industry Buzz Makes News"
ACCESSWIRE - Tue Jan 21, 10:12AM CST
Stevia First Corp's (OTCQB: STVF) CEO, Robert Brooke, published a new blog post today on The Chairman's Blog about the rise of enthusiasm and interest in stevia. TheChairmansBlog.com is an exclusive online media publication that provides key executive officers and key opinion leaders a unique platform to share insights about company and industry trends.
Stand Up Pouches Delivers Sweet Results for Steviva Products
PRWeb - Thu Jan 16, 2:53AM CST
Pouch packing supplier, StandUpPouches.net, recently released a branded eBook for Steviva Brands, Inc.—an Oregon-based manufacturer of stevia products and other bulk ingredient sweetners. Titled Stevia Packaging Uses Stand Up Pouches, the eBook profiles stevia's growing popularity among consumers (thanks to its calorie-free, diabetic-friendly, all-natural composition).
Pure Via(R) Using Only Non-GMO Ingredients
Business Wire - Mon Jan 13, 12:55PM CST
Whole Earth Sweetener Company LLC today announced that it has launched a new Pure Via(R) produced with Non-GMO ingredients. Pure Via(R) is the first global brand of all-natural sweetener to promote this choice in the United States. The change affects both Pure Via(R) and Pure Via(R) Turbinado Raw Cane Sugar & Stevia Blend.
NMA Calls EPA's Power Plant Rule a Reckless Gamble with the Economy
PR Newswire - Tue Jan 07, 11:05AM CST
National Mining Association (NMA) President and CEO Hal Quinn issued the following statement in advance of the publication of the Environmental Protection Agency's (EPA) proposed New Source Performance Standard for regulating greenhouse gas emissions from new coal-based power plants that generate 40 percent of the nation's electricity:
